Opportunity Information: Apply for RFA AG 22 028
Apply for RFA AG 22 028
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition:Caenorhabditis Intervention Testing Program Data Coordinating Center (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2021-09-21.
- Applicants must submit their applications by 2021-10-27. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2025.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required)
Previous opportunity: WATER RESOURCES RESEARCH ACT PROGRAM NATIONAL COMPETITIVE GRANTS FY2025 PROGRAM ANNOUNCEMENT For AQUATIC INVASIVE SPECIES
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 22 028
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 22 028) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition: Renewal of the Caenorhabditis Intervention Testing Program (U01 Clinical Trial Not Allowed) Apply for RFA AG 22 029 Funding Number: RFA AG 22 029 Funding Amount: $600,000 |
| Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Testing Laboratories (U01 Clinical Trial Not Allowed) Apply for RFA NS 22 003 Funding Number: RFA NS 22 003 Funding Amount: $400,000 |
| Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) Apply for RFA HL 23 014 Funding Number: RFA HL 23 014 Funding Amount: $250,000 |
| Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) Apply for RFA HL 23 013 Funding Number: RFA HL 23 013 Funding Amount: Case Dependent |
| Enhanced surveillance of persons with early and late HIV diagnosis to understand system and individual factors associated with new infection and delayed testing Apply for CDC RFA PS22 2211 Funding Number: CDC RFA PS22 2211 Funding Amount: Case Dependent |
| Partnerships for Rapid Diagnostics and Phenotypic Antibacterial Susceptibility Testing for Bacteremia or Hospital Acquired Pneumonia (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 010 Funding Number: RFA AI 22 010 Funding Amount: Case Dependent |
| Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 016 Funding Number: RFA AI 22 016 Funding Amount: $500,000 |
| Mass Mailing of HIV Self-Tests to Persons Disproportionately Affected by HIV in the U.S. Apply for CDC RFA PS22 2210 Funding Number: CDC RFA PS22 2210 Funding Amount: Case Dependent |
| Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required) Apply for RFA MD 22 009 Funding Number: RFA MD 22 009 Funding Amount: $500,000 |
| Ryan White HIV/AIDS Program Part B States/Territories Supplemental Grant Program Apply for HRSA 23 055 Funding Number: HRSA 23 055 Funding Amount: $9,000,000 |
| Network for Personalization of Diagnostic Tests for Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) in Older Adults with Multiple Chronic Conditions (MCCs) (U24 Clinical Trial Optional) Apply for RFA AG 23 032 Funding Number: RFA AG 23 032 Funding Amount: $1,150,000 |
| Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) Apply for PAR 23 032 Funding Number: PAR 23 032 Funding Amount: $350,000 |
| Testing Centers for Development of Somatic Cell Genome Editing in Model Organisms (U42) (Clinical Trials Not Allowed) Apply for PAR 23 038 Funding Number: PAR 23 038 Funding Amount: $500,000 |
| Renewal of the Interventions Testing Program (U01 Clinical Trial Not Allowed) Apply for RFA AG 24 002 Funding Number: RFA AG 24 002 Funding Amount: $3,000,000 |
| Interventions Testing Program (ITP) Data Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA AG 24 003 Funding Number: RFA AG 24 003 Funding Amount: $200,000 |
| Pilot Studies to Test the Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34 Clinical Trial Required) Apply for PAR 23 104 Funding Number: PAR 23 104 Funding Amount: Case Dependent |
| Ryan White HIV/AIDS Program Part B States/Territories Supplemental Grant Program Apply for HRSA 24 065 Funding Number: HRSA 24 065 Funding Amount: $9,000,000 |
| Strengthening Delivery of Quality and Equitable Public Health Services for Prevention, Testing, Care, and Treatment of HIV in Jamaica and Trinidad and Tobago under PEPFAR Apply for CDC RFA GH 24 0100 Funding Number: CDC RFA GH 24 0100 Funding Amount: Case Dependent |
| Ryan White HIV/AIDS Program Part B States/Territories Supplemental Grant Program Apply for HRSA 25 048 Funding Number: HRSA 25 048 Funding Amount: Case Dependent |
| Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) Apply for RFA AG 25 011 Funding Number: RFA AG 25 011 Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 22 028", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.